While efforts to understand how the AHR affects tumor migration, invasion, EMT and metastasis have focused on classic cancer progression-associated genes discussed above, one significant contributor could be one of the most obvious AHR target genes, CYP1B1, especially in hormone-driven cancers. Here, CYP1B1 is linked to neoplasm.